Related Experiment Video
Updated: Aug 4, 2026
06:58
Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
Published on: June 25, 2016
[Epilepsy and pregnancy. Prospective study of 100 cases]
S Garza-Morales1, J M Ibarra-Puig, A Poblano-Luna
1Depto. Neurología Perinataly, Instituto Nacional de Perinatología, SSA.
Ginecologia Y Obstetricia De Mexico
|October 1, 1996
Summary
Pregnancy in women with epilepsy is manageable with careful monitoring of antiepileptic drugs (AEDs). This study found few complications and no major fetal malformations in 100 Mexican women, highlighting effective obstetric and neurologic care.
Area of Science:
- Neurology
- Obstetrics & Gynecology
- Pharmacology
Context:
- Epilepsy during pregnancy presents risks to both mother and fetus due to potential antiepileptic drug (AED) toxicity.
- Managing epilepsy in pregnant women requires careful consideration of drug efficacy and safety profiles.
- The Valley of Mexico serves as the study's geographic focus for this cohort.
Purpose:
- To prospectively evaluate the obstetric and neurologic outcomes of 100 pregnant women with epilepsy.
- To assess the serum levels (SL) of antiepileptic drugs (AEDs) and their correlation with seizure control.
- To identify potential complications, pharmacologic recommendations, and teratogenic risks associated with AED use during pregnancy.
Summary:
- A prospective study of 100 pregnant epileptic women in Mexico monitored clinical status and AED serum levels (SL).
- Most women received monotherapy with phenytoin, carbamazepine, or valproate; SLs were generally within therapeutic ranges.
- Seizure control was maintained in most patients, with obstetric complications not differing from healthy pregnancies; 12% showed minor dysmorphic features, with no major malformations observed.
Impact:
- This study provides crucial data on the management and outcomes of epilepsy during pregnancy in a specific population.
- Findings support the safety of carefully monitored AED use, with low rates of major fetal malformations.
- Highlights the importance of integrated obstetric and neurologic follow-up for pregnant women with epilepsy.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:13Seizures: Classification
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
01:20Seizures l: Introduction
Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
01:22Epilepsy ll: Types
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.